Impact Investing in Cardiovascular Disease

Broadview’s mission is to accelerate the development of promising technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.

Getting Treatments to Patients

Broadview’s mission is to accelerate the development of promising technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.

Diversified Portfolio Across Technologies

Broadview’s mission is to accelerate the development of promising technology for the diagnosis and treatment of cardiovascular disease and stroke through targeted investments.

OUR PORTFOLIO

View All

PRESS

Sep 8, 2025
Broadview Ventures Appoints Cardiovascular Leader and MedTech Executive Ian Meredith, MBBS, PhD to its Strategic Advisory Board
Read More
Sep 4, 2025
Edwards buys remaining stake of Vectorious Medical Technologies and its heart implant
Read More
Aug 12, 2025
Cardiosense Appoints Medtech Executive John Martin, MD as EVP and Chief Medical Officer
Read More
Jul 30, 2025
Cardiosense Receives FDA 510(k) Clearance for the CardioTag™ Device, Paving the Way for Advanced Cardiac Function Monitoring
Read More
View All